1 |
Arcaro A. Targeted therapies for small cell lung cancer: Where do we stand? Crit Rev Oncol Hemat. 2015;95(2):154-64.
DOI
|
2 |
van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741-55.
DOI
|
3 |
Stupp R, Monnerat C, Turrisi AT, 3rd, Perry MC, Leyvraz S, Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 2004;45(1):105-17.
DOI
|
4 |
De Ruysscher D, Botterweck A, Dirx M, Pijls-Johannesma M, Wanders R, Hochstenbag M, et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Annals of Oncology, 2009;20(1):98-102.
DOI
|
5 |
Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database. Journal of Clinical Oncology. 2007;25(35):5570-7.
DOI
|
6 |
Kato Y, Ferguson TB, Bennett DE, Burford TH. Oat cell carcinoma of the lung. A review of 138 cases. Cancer. 1969;23(3):517-24.
DOI
|
7 |
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nature medicine. 2013;19(11):1423-37.
DOI
|
8 |
Chabner BA, Roberts TG. Timeline - Chemotherapy and the war on cancer. Nature Reviews Cancer. 2005;5(1):65-72.
DOI
|
9 |
Kang CH, Kang H, Shin HK, Shim BS, Kim SH, Choi SH, et al. Experimental Studies on the Anti-angiogenesis and Anti-metastasis Effects of Ekong-san. Journal of Korean traditional oncology. 2006;11(1):41-54.
|
10 |
Lee SG, Ha JH. Antitumor and immunomodulatory effects of Ikongsan on murine melanoma-induced lung metastasis. Koren Journal of Oriental Medical Pathology. 1997;11(1):21-30.
|
11 |
Choi W, Jung H, Kim K, Lee S, Yoon S, Park J, et al. Rhus verniciflua Stokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center. Journal of biomedicine & biotechnology. 2012;2012:874276.
|
12 |
Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh S, Nagayama A. Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol. 2004;4(2):317-24.
DOI
|
13 |
Nabeshima S, Murata M, Hamada M, Chong Y, Yamaji K, Hayashi J. Maturation of monocytederived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine. Int Immunopharmacol. 2004;4(1):37-45.
DOI
|
14 |
Li T, Tamada K, Abe K, Tada H, Onoe Y, Tatsugami K, et al. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang). Immunopharmacology. 1999;43(1):11-21.
DOI
|
15 |
Szasz A. Current status of oncothermia therapy for lung cancer. The Korean journal of thoracic and cardiovascular surgery. 2014;47(2):77-93.
DOI
|
16 |
Hegyi G, Szigeti GP, Szasz A. Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:672873.
|
17 |
Melzer J, Iten F, Hostanska K, Saller R. Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases A Systematic Review. Forschende Komplementarmedizin. 2009;16(4):217-26.
|
18 |
Elluru SR, Van Huyen JPD, Delignat S, Prost F, Heudes D, Kazatchkine MD, et al. Antiangiogenic Properties of Viscum Album Extracts Are Associated with Endothelial Cytotoxicity. Anticancer research. 2009;29(8):2945-50.
|